Table 1 of Hou, Mol Vis 2008; 14:2597-2603. Table 1 of Hou, Mol Vis 2008; 14:2597-2603.
Table 1. HLA-DR4 and HLA-DRw53 distribution and clinical findings of patients with VKH syndrome.
Characteristics |
VKH Patients | |||
|---|---|---|---|---|
| HLA-DR4 + | HLA-DR4 - | HLA-DRw53 + | HLA-DRw53 - | |
| Number of patients (%) | 179 (77.5%) | 52 (22.5%) | 203 (87.9%) | 28 (12.1%) |
| Male | 103 (80.5%) | 25 (19.5%) | 116 (90.6%) | 12 (9.4%) |
| Female | 76 (73.8%) | 27 (26.2%) | 87 (84.5%) | 16 (15.5%) |
| Neck stiffness | 74 (72.5%) | 28 (27.5%) | 89 (87.3%) | 13 (12.7%) |
| Alopecia | 26 (72.2%) | 10 (27.8%) | 30 (83.3%) | 6 (16.7%) |
| Poliosis | 65 (73.9%) | 23 (26.1%) | 78 (88.6%) | 10 (11.4%) |
| Vitiligo | 41 (74.5%) | 14 (25.5%) | 48 (87.3%) | 7 (12.7%) |
| Dysacusia | 57 (69.5%) | 25 (30.5%) | 70 (85.4%) | 12 (14.6%) |
| Tinnitus | 61 (84.7%) | 11 (15.3%) | 67 (93.1%) | 5 (6.9%) |
| Scalp hypersensitivity | 32 (74.4%) | 11 (25.6%) | 38 (88.4%) | 5 (11.6%) |